3D Global Biotech Inc. (TPEX:6808)
Taiwan · Delayed Price · Currency is TWD 49.85
-0.05 (-0.10%)
Sep 17, 2025, 1:59 PM CST
3D Global Biotech Revenue
3D Global Biotech had revenue of 222.02M TWD in the half year ending December 31, 2024, with 2,951.84% growth. This brings the company's revenue in the last twelve months to 324.87M, up 489.06% year-over-year. In the year 2024, 3D Global Biotech had annual revenue of 265.69M with 1,187.68% growth.
Revenue (ttm)
324.87M
Revenue Growth
+489.06%
P/S Ratio
11.91
Revenue / Employee
7.56M
Employees
43
Market Cap
3.87B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 265.69M | 245.05M | 1,187.68% |
| Dec 31, 2023 | 20.63M | 6.99M | 51.24% |
| Dec 31, 2022 | 13.64M | 2.57M | 23.19% |
| Dec 31, 2021 | 11.08M | -2.19M | -16.48% |
| Dec 31, 2020 | 13.26M | -4.92M | -27.05% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Caliway Biopharmaceuticals | 44.83M |
| PharmaEssentia | 12.63B |
| Bora Pharmaceuticals Co., LTD. | 21.32B |
| Lumosa Therapeutics | 37.25M |
| Lotus Pharmaceutical | 19.12B |
| Oneness Biotech | 112.57M |
| Polaris Group | 64.02M |
| Center Laboratories | 1.60B |